Agile Therapeutics Inc (AGRX) stock has risen 158.82% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives AGRX stock a score of 82 out of a possible 100.
That rank is influenced by a fundamental score of 94. In addition to the average rating from Wall Street analysts, AGRX stock has a mean target price of 8.5. This means analysts expect the stock to add 175.97% over the next 12 months. AGRX's rank also includes a short-term technical score of 83. The long-term technical score for AGRX is 68.
What's Happening with AGRX Stock Today
Agile Therapeutics Inc (AGRX) stock is higher by 8.27% while the S&P 500 has fallen -0.15% as of 3:02 PM on Tuesday, Sep 29. AGRX has risen $0.24 from the previous closing price of $2.84 on volume of 1,541,769 shares. Over the past year the S&P 500 has risen 12.43% while AGRX has risen 158.82%. AGRX lost -$0.41 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Agile Therapeutics Inc (AGRX) Stock.
